BARGE member profile — Dr Esther Brandon

Dr Esther Brandon

Antonie van Leeuwenhoeklaan 9
3721 MA Bilthoven
The Netherlands



Brandon, E F A, Bakker, M I, Kramer, E, Bouwmesster, H, Zuidema, T, and Alewijn, M.  2014.  Bioaccessibility of vitamin A, vitamin C and folic acid from dietary supplements, fortified food and infant formula.  International Journal of Food Sciences and Nutrition, 65, 426–435.

Brandon, E F A, Janssen, P J C M, and de Wit-Bos, L.  2014.  Arsenic: bioaccessibility from seaweed and rice, dietary exposure calculations and risk assessment.  Food Addititives Contaminants, Part A, 31, 1993–2003.


Wragg, J, Cave, M, Basta, N, Brandon, E, Casteel, S, Denys, S, Gron, C, Oomen, A, Reimer, K, Tack, K, and Van de Wiele, T.  2011.  An inter-laboratory trial of the unified BARGE bioaccessibility method for arsenic, cadmium and lead in soil.  Science of The Total Environment, 409, 4016–4030


Kabak, B, Brandon, E F A, Var, I, Blokland, M, and Sips, A J A M.  2009.  Effects of probiotic bacteria on the bioaccessibility of aflatoxin B1 and ochratoxin A using an in vitro digestion model under fed conditions.  Journal of Environmental Science and Health, Part B, 44, 472–480


Brandon, E F A, Oomen, A G, Rompelberg, C J M, Versantvoort, C H M, van Engelen, J G M, and Sips, A J A M.  2006.  Consumer product in vitro digestion model: bioaccessibility of contaminants and its application in risk assessment.  Regulatory Toxicology and Pharmac, 44, 161–171

Oomen, A G, Brandon, E F A, Swartjes, F A, Lijzen, J P A, and Sips, A J A M.  2006.  How can information on oral bioavailability improve human-health risk assessment for lead-contaminated soils? Implementation and scientific basis.  Epidemiology, 17